Media

Aprea Therapeutics Announces Removal of FDA Clinical Hold on Eprenetapopt in Lymphoid Malignancies

Carisma Therapeutics Announces Collaboration with Merck to Evaluate CAR-Macrophages in Combination with KEYTRUDA® (pembrolizumab) in a Clinical Study

Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders

Nordic Nanovector R&D Day: Building Value from Betalutin® and a pipeline of broader therapeutic opportunities targeting CD37

Carisma Therapeutics Appoints Sanford Zweifach as Chairman to Board of Directors

Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer

Oncopeptides publishes Q3 2021 report

Invitation to presentation of the Q3 2021 results